Showing 41,841 - 41,860 results of 44,556 for search '"medicine"', query time: 0.21s Refine Results
  1. 41841
  2. 41842

    Lipid Coating Modulates Effects of Nanoceria on Oxidative Metabolism in Human Embryonic Lung Fibroblasts: A Case of Cardiolipin by Elena V. Proskurnina, Madina M. Sozarukova, Elizaveta S. Ershova, Ekaterina A. Savinova, Larisa V. Kameneva, Natalia N. Veiko, Maria A. Teplonogova, Vladimir P. Saprykin, Vladimir K. Ivanov, Svetlana V. Kostyuk

    Published 2025-01-01
    “…The unique redox properties of nanoscale cerium dioxide determine its diverse application in biology and medicine as a regulator of oxidative metabolism. Lipid modifiers of the nanoparticle surface change their biochemical properties and bioavailability. …”
    Get full text
    Article
  3. 41843
  4. 41844
  5. 41845
  6. 41846
  7. 41847
  8. 41848
  9. 41849
  10. 41850
  11. 41851
  12. 41852
  13. 41853
  14. 41854
  15. 41855
  16. 41856
  17. 41857
  18. 41858
  19. 41859

    Perspectives of People with Type 2 Diabetes Mellitus Towards a Decision Aid Assessing Preferences of Glucose-Lowering Drugs: The Dilemma of Choosing by Roldan Munoz S, Mol PGM, de Vries F, van Dijk PR, Hillege H, Postmus D, de Vries ST

    Published 2025-01-01
    “…Sonia Roldan Munoz,1 Peter GM Mol,1 Femke de Vries,2 Peter R van Dijk,3 Hans Hillege,4 Douwe Postmus,4 Sieta T de Vries1 1Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands; 2Faculty of Beta Science, Vrije Universiteit Amsterdam, Amsterdam, Netherlands; 3Division of Endocrinology, Department of Internal Medicine, University of Groningen, University Medical Center Groningen, Groningen, Netherlands; 4Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, NetherlandsCorrespondence: Sieta T de Vries, Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, Email s.t.de.vries@umcg.nlBackground: Treatment guidelines recommend metformin as initial drug in many people with type 2 diabetes (T2D) and low risk of cardiovascular disease, with the possibility to switch to or add other drug classes. …”
    Get full text
    Article
  20. 41860